Pentamidine Isethionate Injection shortage
Not a nationwide shortage — XGen Pharmaceuticals DJB has told the FDA it is discontinuing its pentamidine isethionate injections.
- The FDA lists this under “To be discontinued” as of Nov 21, 2026: a company stopping its own product.
- 4 other companies sell the same medicine and have not reported a problem, so your pharmacy may be able to order another company’s version.
- Status
- FDA term: “To Be Discontinued”
- Products on the record
- 1
- Category
- First posted
- Mar 23, 2026
- Last updated
- Mar 23, 2026
This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD Compiled from public FDA (openFDA) and CMS (Medicaid) data sources. Editorial policy
The Bottom Line
XGen Pharmaceuticals is permanently stopping its pentamidine isethionate injection. Other manufacturers — including Fresenius Kabi and Seton Pharmaceuticals — still list this medicine, including Pentam 300 (pentamidine isethionate) 300 mg, so supply may be available from other sources.
Don’t stop or change your therapy on your own — talk with your prescriber about the plan that fits you, and ask your pharmacist what’s actually available (see options).
Is Pentamidine Isethionate Being Discontinued? Status as of Nov 21, 2026
Not as a whole, as of Nov 21, 2026. XGen Pharmaceuticals DJB is stopping its own version only; 4 other companies still sell the same medicine and have not reported a problem. Your pharmacy may need to order another company’s version.
The charts count only the companies that reported this shortage to the FDA; companies that haven’t reported a problem are listed after them, and the Supply-Risk rating counts them too.
Availability of the Affected Products
From the FDA shortage report: 1 product
Is Every Strength Still Made?
A medicine often comes in several strengths, and more than one company may make each. This shows whether at least one company still makes each strength on the record: a company on the shortage report that still has supply, or another company that sells it.
1 of 1 strength
- 300 mg/3 mLStill made by a company
Other Companies Listing the Same Medicine, Not Reporting a Shortage
Companies that list Pentamidine Isethionate Injection with the FDA and have not reported a shortage (not counted in the charts above).
- PAI Holdings, LLC dba PAI Pharma
- Seton Pharmaceuticals
- Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.
- Fresenius Kabi USA, LLC
Plus 4 other dosage forms of pentamidine isethionate.
Shortage Timeline
- Mar 23, 2026 Discontinuation notice on file 1 of 1 product affected.
- Mar 23, 2026 First reported to the FDA 1 product first listed.
Built from FDA posting and update dates. The end date FDA publishes is the posting/update date, not a true resolution date, so durations are approximate.
Which Pentamidine Isethionate Products Are Affected, by Company
Only the companies that told the FDA about a supply problem are listed here, so other companies may still have stock (see Where else can I get pentamidine isethionate?).
Company: XGen Pharmaceuticals DJB, Inc.
-
Pentamidine Isethionate Injection, 300 mg/3 mL
- Strength
- 300 mg/3 mL
- Availability
- Not stated
Notes: A business decision was made to discontinue manufacture of the drug.
Why Is XGen Pharmaceuticals DJB Discontinuing Pentamidine Isethionate?
A note from Dr. Brian Staiger, PharmD · Written Oct 7, 2026
XGen Pharmaceuticals has made a business decision to permanently stop making their version of Pentamidine Isethionate Injection 300 mg/3 mL (the vial size identified as NDC 39822-3050-2). No specific reason beyond it being a business decision was shared publicly — they didn't give a more detailed explanation.
It's worth knowing that this report only covers XGen Pharmaceuticals' product. It doesn't mean this medication is going away from every company that makes it — other manufacturers may still be producing their own versions, and those are tracked separately.
What Should I Do If I Take Pentamidine Isethionate?
A note from Dr. Brian Staiger, PharmD · Written Oct 7, 2026
Pentamidine Isethionate Injection is currently on the FDA shortage list. I want to walk you through what this means and the steps you can take.
The one strength involved here is 300 mg/3 mL. The manufacturer reporting this — XGen Pharmaceuticals — has made a business decision to discontinue making it, so this particular supply issue may be permanent rather than temporary. Because this is a planned discontinuation, a conversation with your prescriber or pharmacist is the right next step to plan ahead.
It's important to know this report reflects only the one company that filed it. The same medicine is still listed by other makers, so it may still be obtainable through your pharmacy.
Here is what I suggest, in order:
- Do not stop, skip, or change your doses on your own.
- Ask your pharmacy to source this medicine — the same ingredient is also made by PAI Pharma, Seton Pharmaceuticals, Avet Pharmaceuticals, and Fresenius Kabi (Pentam 300). Your pharmacy can check wholesalers and these makers, though a given product may not be in local stock.
- If your exact product cannot be found, ask your prescriber or pharmacist about a clinician-chosen option.
- Manufacturer contact numbers are listed on this page for reference; pharmacies usually handle those calls.
This is general, national information and may not match your local pharmacy's actual stock.
Quick checklist for the pharmacy counter
- Ask your pharmacy to check other companies’ versions, other strengths, package sizes, and nearby stores — the options below are a starting point.
- If this is part of an ongoing or essential regimen (for example HIV, seizure, heart, transplant, diabetes or mental-health medicines), arrange continued supply before you run out rather than rationing doses.
Where Else Can I Get Pentamidine Isethionate?
From the current FDA NDC Directory: the same medicine from companies that have not reported a shortage and other dosage forms.
- Some listings are repackagers, which relabel another company’s product.
- A listing is not stock: these may still be out of stock at your pharmacy, and only your prescriber or pharmacist can decide what’s right for you.
Same Medicine From Other Companies (Not Reporting a Shortage)
The same active ingredient, dosage form and route, from companies that have not reported a shortage to the FDA.
| Product | Strength | Form / route | Company | NDC |
|---|---|---|---|---|
| Pentamidine Isethionate | 300 mg/300 mg | Injection, Powder, Lyophilized, For Solution · Intramuscular, Intravenous | PAI Holdings, LLC dba PAI Pharma | 00121-1101-02 |
| Pentamidine Isethionate | 300 mg/300 mg | Injection, Powder, Lyophilized, For Solution · Intramuscular, Intravenous | Seton Pharmaceuticals | 13925-0515-10 |
| Pentamidine Isethionate | 300 mg/300 mg | Injection, Powder, Lyophilized, For Solution · Intramuscular, Intravenous | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 23155-0748-41 |
| Pentam 300 | 300 mg/3 mL | Injection, Powder, Lyophilized, For Solution · Intramuscular, Intravenous | Fresenius Kabi USA, LLC | 63323-0113-10 |
Other Dosage Forms of Pentamidine Isethionate
A different form of the same drug (for example a solution when capsules are short). A form change is a clinical decision — ask your prescriber:
Inhalant
- Pentamidine Isethionate — PENTAMIDINE DIISETHIONATE 300 mg/300mgPAI Holdings, LLC dba PAI Pharma · Respiratory (Inhalation)
- Pentamidine Isethionate — PENTAMIDINE ISETHIONATE 300 mg/300mgSeton Pharmaceuticals · Respiratory (Inhalation)
- Pentamidine Isethionate — PENTAMIDINE ISETHIONATE 300 mg/6mLXGen Pharmaceuticals DJB, Inc. · Respiratory (Inhalation)
- Nebupent — PENTAMIDINE ISETHIONATE 300 mg/6mLFresenius Kabi USA, LLC · Respiratory (Inhalation)
Therapeutic Equivalents and Pricing 5 products
Other products the FDA rates as interchangeable with the affected strengths, with what pharmacies pay for each and whether pharmacies are still buying it. Cheapest first.
| Product | Manufacturer | Package | Pharmacy cost per unit (NADAC) | FDA rated equivalent | Availability |
|---|---|---|---|---|---|
| Pentamidine Isethionate 300 mg/300mgNDC 00121-1101-02 | PAI | 10 vials | — | AP | FDA listed |
| Pentamidine Isethionate 300 mg/300mgNDC 13925-0515-10 | Seton | 10 vials | — | AP | FDA listed |
| pentamidine isethionate 300 mg/300mgNDC 23155-0748-41 | Heritage | 10 vials | — | AP | FDA listed |
| Pentamidine Isethionate 300 mg/3mLNDC 39822-3050-02 | XGen | 10 vials | — | — | Discontinued |
| Pentam 300 300 mg/3mLNDC 63323-0113-10 | Fresenius | 10 vials | — | AP | FDA listed |
These have the same ingredient, strength, form and route, and the FDA rates them as substitutes (an “AB” rating in its Orange Book). The price is what pharmacies pay on average (CMS’s NADAC survey), not what you pay. Availability comes from recent pharmacy prices, not a stock check.
Other Drugs in the Same Treatment Class
These are different medicines — not other versions of pentamidine isethionate — that fall in the same broad treatment class (antiprotozoal drugs,miscellaneous). They are not automatic substitutes: they can differ in how they work, dosing, effectiveness, side effects and what they’re approved to treat. Do not switch on your own. This list is for information only — ask your prescriber or pharmacist whether any of them is appropriate for you.
Codes & Classification for pharmacists and billers
- GCN Seq No
- 009599
- GCN
- 42990
- HICL code
- 004162
- Ingredient (HICL)
- Pentamidine Isethionate
- HIC1 code
- W
- Therapeutic class — broad (HIC1)
- Anti-Infecting Agents
- HIC2 code
- W4
- Therapeutic class — intermediate (HIC2)
- Antiparasitics
- HIC3 code
- W4K
- Therapeutic class — specific (HIC3)
- Antiprotozoal Drugs,Miscellaneous
- AHFS code
- 08:30.12.00
- AHFS class
- Antiprotozoals, P Jirovecii Pneumonia
- FDB label name
- PENTAMIDINE 300 MG INJECT VIAL
- FDB brand name
- Pentamidine Isethionate
- Legend status
- F — Federal legend — prescription drug or device
Where does this data come from? Identity codes come from First Databank (FDB) (HICL ingredient, HIC1–3 therapeutic-class hierarchy, GCN, AHFS class, legend status) and Medi-Span GPI, mapped from a representative affected NDC. Licensed reference data — for identification only.
Other Anti-Infective Shortages
- Demeclocycline Hydrochloride TabletA company is discontinuing its version · 1 product
- Cefazolin in Dextrose InjectionA company is discontinuing its version · 3 products
- Ceftriaxone Sodium InjectionA company is discontinuing its version · 2 products
- CiproA company is discontinuing its version · 1 product
- STROMECTOL (Ivermectin) TabletA company is discontinuing its version · 1 product
- Micafungin Sodium InjectionA company is discontinuing its version · 2 products
- RECARBRIO (Imipenem Anhydrous, Cilastatin, and Relebactam Anhydrous) InjectionA company is discontinuing its version · 1 product
- Doxycycline Hyclate Delayed-Release TabletA company is discontinuing its version · 2 products
Pentamidine isethionate Shortage FAQs
Is pentamidine isethionate discontinued?
Only XGen Pharmaceuticals DJB’s version. XGen Pharmaceuticals DJB has told the FDA it is stopping its own product (listed under “To be discontinued” as of Nov 21, 2026), while 4 other companies still sell the same medicine and have not reported a problem (PAI Holdings, LLC dba PAI Pharma, Seton Pharmaceuticals, Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals and 1 more). It is not a nationwide shortage.
Which strengths of pentamidine isethionate are affected?
The FDA record covers 1 strength: 300 mg/3 mL. Every strength on the record is still made by at least one company, though stock varies by pharmacy.
Why is XGen Pharmaceuticals DJB discontinuing pentamidine isethionate?
XGen Pharmaceuticals DJB’s note on the FDA record says: “A business decision was made to discontinue manufacture of the drug.”
Which pentamidine isethionate products are affected?
Pentamidine Isethionate Injection, 300 mg/3 mL (NDC 39822-3050-02). The full per-NDC list (availability, company and status) is in the table above — each NDC links to its own page.
When will pentamidine isethionate be available again?
A discontinuation is usually permanent for that company’s product. The same medicine is still sold by PAI Holdings, LLC dba PAI Pharma, Seton Pharmaceuticals, Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals and 1 more, so ask your pharmacy to order another company’s version.
Can I still get pentamidine isethionate somewhere?
Other companies (PAI Holdings, LLC dba PAI Pharma, Seton Pharmaceuticals, Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals and 1 more) sell the same medicine and have not reported a problem. 4 other dosage forms of pentamidine isethionate are also listed. See “Where else can I get pentamidine isethionate?” above — stock still varies by pharmacy.
What should I do if I take pentamidine isethionate?
Don’t stop or change it on your own. Ask your pharmacist whether they can order it from another company or a different strength or package size, and ask your prescriber about a long-term plan before your supply runs out.
How to Read the Supply-Risk Rating
Each drug in shortage gets one point for each of five risk factors that apply to it (listed with its rating). It is our estimate across the country, not a check of your pharmacy’s shelves.
- Low0 to 2 risk factors Your pharmacy can often still get it, though it may need to be ordered.Pentamidine isethionate is rated Low: 0 of 5 risk factors.
- Medium3 risk factors Supply is tight in several ways. Finding it may take some calling around.
- High4 or 5 risk factors, or no company found making it Few companies are left making it, or some strengths have no maker at all. It may be hard to find for a while.
Back to this drug’s rating ↑ · How we rate supply risk, in full
Where This Data Comes From
- The FDA’s drug shortage database, checked every day: the companies, their products and the codes on their boxes (NDCs), the status, the reason and the dates. See the FDA’s record for this shortage ↗
- The FDA’s NDC Directory: the other companies that make the same medicine, which the supply-risk rating counts.
- First Databank and CMS NADAC: matching the same medicine across companies, and what pharmacies pay for the equivalents.
For reference only. Check with your pharmacist, the drug’s maker or the FDA before acting on it.